Literature DB >> 20851715

Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.

Jae-Min Song1, Yeu-Chun Kim, Peter G Barlow, M Jaber Hossain, Kyoung-Mi Park, Ruben O Donis, Mark R Prausnitz, Richard W Compans, Sang-Moo Kang.   

Abstract

To develop a more effective vaccination method against H5N1 virus, we investigated the immunogenicity and protective efficacy after skin vaccination using microneedles coated with influenza virus-like particles containing hemagglutinin derived from A/Vietnam/1203/04 H5N1 virus (H5 VLPs). A single microneedle vaccination of mice with H5 VLPs induced increased levels of antibodies and provided complete protection against lethal challenge without apparent disease symptoms. In contrast, intramuscular injection with the same vaccine dose showed low levels of antibodies and provided only partial protection accompanied by severe body weight loss. Post-challenge analysis suggested that improved protection was associated with lower lung viral titers and enhanced generation of recall antibody secreting cells by microneedle vaccination. Thus, this study provides evidence that skin delivery of H5 VLP vaccines using microneedles designed for self-administration induces improved protection compared to conventional intramuscular immunization.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851715      PMCID: PMC2980851          DOI: 10.1016/j.antiviral.2010.09.001

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  29 in total

1.  Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

Authors:  Pierre Van Damme; Froukje Oosterhuis-Kafeja; Marie Van der Wielen; Yotam Almagor; Ofer Sharon; Yotam Levin
Journal:  Vaccine       Date:  2008-11-18       Impact factor: 3.641

2.  Summary recommendations by the Advisory Committee on Immunization Practices (ACIP) for the use of H1N1 influenza vaccine for the 2009-2010 vaccination season.

Authors:  Sheila M Litchfield
Journal:  AAOHN J       Date:  2009-09

Review 3.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

4.  Improved influenza vaccination in the skin using vaccine coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

5.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

6.  Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.

Authors:  Qiyun Zhu; Vladimir G Zarnitsyn; Ling Ye; Zhiyuan Wen; Yulong Gao; Lei Pan; Ioanna Skountzou; Harvinder S Gill; Mark R Prausnitz; Chinglai Yang; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

7.  Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Authors:  Joel R Haynes; Leslie Dokken; James A Wiley; Andrew G Cawthon; John Bigger; Allen G Harmsen; Charles Richardson
Journal:  Vaccine       Date:  2008-11-19       Impact factor: 3.641

8.  Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

Authors:  Sang-Moo Kang; Dae-Goon Yoo; Aleksandr S Lipatov; Jae-Min Song; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Ruben O Donis; Richard W Compans
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

9.  Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Dae-Goon Yoo; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

10.  Transdermal influenza immunization with vaccine-coated microneedle arrays.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Sean P Sullivan; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more
  29 in total

1.  DNA vaccination in the skin using microneedles improves protection against influenza.

Authors:  Jae-Min Song; Yeu-Chun Kim; Eunju O; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

2.  Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

Authors:  Min-Chul Kim; Yu-Na Lee; Eun-Ju Ko; Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Jae-Min Song; Byung-Min Song; Youn-Jeong Lee; Jun-Gu Choi; Hyun-Mi Kang; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

Review 3.  The success of microneedle-mediated vaccine delivery into skin.

Authors:  Sarah Marshall; Laura J Sahm; Anne C Moore
Journal:  Hum Vaccin Immunother       Date:  2016-04-06       Impact factor: 3.452

Review 4.  Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems.

Authors:  Xueting Wang; Ning Wang; Ning Li; Yuanyuan Zhen; Ting Wang
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

Review 5.  Advances in novel influenza vaccines: a patent review.

Authors:  Jae-Min Song
Journal:  J Microbiol       Date:  2016-05-27       Impact factor: 3.422

6.  Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza.

Authors:  M Jaber Hossain; Melissa Bourgeois; Fu-Shi Quan; Aleksandr S Lipatov; Jae-Min Song; Li-Mei Chen; Richard W Compans; Ian York; Sang-Moo Kang; Ruben O Donis
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

Review 7.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

8.  Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus.

Authors:  Min-Chul Kim; Jae-Min Song; Eunju O; Young-Man Kwon; Youn-Jeong Lee; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2012-12-18       Impact factor: 11.454

9.  Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.

Authors:  Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Yu-Na Lee; Eun-Ju Ko; Si-Eun Yoo; Min-Chul Kim; Ki-Hye Kim; Min Kyoung Cho; Young-Tae Lee; You Ri Lee; Fu-Shi Quan; Sang-Moo Kang
Journal:  Vaccine       Date:  2014-08-27       Impact factor: 3.641

10.  Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Jae-Min Song; Hye Suk Hwang; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Clin Vaccine Immunol       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.